Skip to main content
ARS Home » Midwest Area » Ames, Iowa » National Animal Disease Center » Infectious Bacterial Diseases Research » Research » Publications at this Location » Publication #370175

Research Project: Pathogenesis and Development of Improved Diagnostic and Control Strategies for Brucellosis in Livestock and Wildlife

Location: Infectious Bacterial Diseases Research

Title: Characterization of the RB51 genome sequence in the context of vaccine properties

item Bricker, Betsy
item GOONESEKERE, NALIN - University Of Northern Iowa
item Bayles, Darrell
item Alt, David
item Olsen, Steven
item Vrentas, Catherine

Submitted to: G3, Genes/Genomes/Genetics
Publication Type: Peer Reviewed Journal
Publication Acceptance Date: 2/23/2020
Publication Date: 4/1/2020
Citation: Bricker, B.J., Goonesekere, N., Bayles, D.O., Alt, D.P., Olsen, S.C., Vrentas, C.E. 2020. Genome report-a genome sequence analysis of the RB51 strain of Brucella abortus in the context of its vaccine properties. G3, Genes/Genomes/Genetics. 10(4):1175-1181.

Interpretive Summary: Whole genome sequencing is a powerful research tool for explaining physiologic and biologic differences between strains. In this report, we sequenced the attenuated brucellosis vaccine strain, Brucella abortus strain RB51 and identified some of the mutations that contribute to its reduced virulence and immunogenicity. The tudy identified genes of interest for future work developing new brucellosis vaccines for other host species.

Technical Abstract: The RB51 vaccine strain of Brucella abortus, which confers safe and effective protection of cattle from B. abortus infection, was originally generated via serial passage of B. abortus 2308 to generate spontaneous, attenuating mutations. While some of these mutations have been previously characterized, such as an insertional mutation in the wboA gene that contributes to the rough phenotype of the strain, a comprehensive annotation of genetic differences between RB51 and B. abortus 2308 genomes has not yet been published. Here, the whole genome sequence of the RB51 vaccine strain is compared against two available 2308 parent sequences, with all observed single nucleotide polymorphisms, insertions, and deletions presented. Mutations of interest for future characterization in vaccine development, such as mutations in eipA and narJ genes in RB51, were identified. Additionally, protein homology modeling was utilized to provide in silico support for the hypothesis that the RB51 capD mutation is the second contributing mutation to the rough phenotype of RB51, likely explaining the inability of wboA-complemented strains of RB51 to revert to a smooth phenotype.